Category: Infectious Diseases
Research Shows Promise For Antiviral Drug to Treat COVID-19
Victor Garcia, PhD, and Angela Wahl, PhD Victor Garcia, PhD, professor of medicine in the division of infectious diseases, and Angela Wahl, PhD, assistant professor, talked with FOX 8 News about the antiviral drug EIDD-2801, which could be the standard way to treat COVID-19, possibly within the next few months. Prior to the pandemic, Garcia and Wahl were working on a new model to … Read more
Women More Likely to Experience Serious Side Effects From COVID-19 Vaccine, CDC Study Reveals
David Wohl, MD David Wohl, MD, professor of medicine in the division of infectious diseases, talked with ABC-11 News about a CDC study that reveals women are more likely to experience serious side effects from COVID-19 vaccines. The CDC study looked at data from the first 13.7 million COVID-19 vaccine doses given to Americans. Among the side effects reported to federal officials, … Read more
Boyce Awarded ‘Caregivers at Carolina’ Research Funding
Ross Boyce, MD, MSc Ross Boyce, MD, MSc, assistant professor of medicine in the division of infectious diseases, has received a Caregivers at Carolina Research Award. Boyce’s research focuses on the epidemiology of vector-borne diseases (i.e. malaria) in rural sub-Saharan Africa as well as the development of appropriate diagnosis and management tools. The goal of the Caregivers a … Read more
Why Should Black Women Participate in Research?
A new UNC Health video encourages Black women to participate in research and features Ada Adimora, MD, MPH, professor of medicine in the division of infectious diseases. Other featured women include Geraldine Bradshaw, principal of the Institute for the Development of Young Leaders, Alicia Diggs, Office of Community Engagement manager for the Center for AIDS research (CFAR), and … Read more
-
Wohl Expresses Concern For Resuming Normal Activities Too Soon.
David Wohl, MD David Wohl, MD, professor of medicine in the division of infectious diseases, expressed concern for North Carolinians resuming normal activities to soon. In a News & Observer article, Wohl said that he worries the current decline in COVID-19 cases is the back slope of the post-holiday surge. He also added the slowing of the decline may reflect the arrival of vi … Read more
Should You Be Concerned About Blood Clots, Bleeding and the AZ-Vaccine?
David Wohl, MD, and Stephan Moll, MD While millions of people in dozens of countries have received the AstraZeneca Covid vaccine with few reports of ill effects, and its prior testing in tens of thousands of people found it to be safe, the vaccine is being investigated. A New York Times article explains the decision to pause the vaccine in European countries, with concerns about … Read more
-
Wohl Discusses Moderna Testing in Young Children, Outreach For Group 4 and Fears Over Side Effects
David Wohl, MD David Wohl, MD, talked with the New York Times about a study that will test the Moderna vaccine in children under 12, including babies as young as six months old. He said the study appears well designed and likely to be efficient, but he questioned why children were to be followed for only one year, when adults in Moderna’s study are followed for two years. He also … Read more
Getting answers: I’m a teacher. How can I best keep my unvaccinated students safe?
Joe Eron, MD Joe Eron, MD, professor of medicine and chief of the division of infectious diseases, was consulted for a CBS17.com news story about when COVID-19 vaccines might be available for school-aged children and precautions that should continue. Read the story here.
UNC Health Marks One Year Since NC’s First COVID-19 Case
David Wohl, MD, and David Weber, MD David Wohl, MD, and David Weber, MD, are featured in a UNC Health video that marks one year since North Carolina’s first COVID-19 case. Published on WRAL.com, the video also includes Wesley Burks, MD, Alexa Mieses-Malchuk, MD, MPH, Samantha Meltzer-Brody, MD, and Melissa Miller, PhD. Watch the video here.
Single Vaccine Dose May Offer Protection to Those Who Have Had COVID-19
Emily Ciccone, MD, MHS UNC-Chapel Hill research, led by Emily Ciccone, MD, MHS, instructor and fellow in the division of infectious diseases, and Allison Aiello, PhD, professor of epidemiology and Carolina Population Center Fellow, shows that individuals previously infected with SARS-CoV-2 develop a significant antibody response to the first dose of mRNA-based COVID-19 vaccines. … Read more
Wohl Talks With Media About Second Doses of Vaccine, Eased NC Restrictions and J&J Vaccine Approval
David Wohl, MD After winter weather delayed the delivery of 6 million vaccine doses nationwide, David Wohl, MD, professor of medicine in the division of infectious diseases, addressed concerns about the supply of second vaccine doses in a WRAL.com interview. He explained how health systems like UNC Health planned ahead and have second doses in reserve. Find the interview here. I … Read more
UNC Health Media Briefing: Sickbert-Bennett Discusses Double-Masking and the Importance of Mask Fit
Emily Sickbert-Bennett, PhD, MS Emily Sickbert-Bennett, PhD, and Phillip Clapp, PhD, spoke with media about research and guidance on wearing masks, double-masking, and the importance of mask material and fit. Find a link to the briefing in the UNC Health and UNC School of Medicine Newsroom. Sickbert-Bennett and Clapp were also featured in a Yahoo News article explaining these gu … Read more